The annual survey revealed that the percentage of Houston-area residents who had a positive view of the local job market dropped slightly. Photo via Getty Images

Few studies gauge the barometric pressure of the Bayou City like the Kinder Houston Area Survey.

Designed to take the temperature of the general population, the study — now in its 40th year — reveals a Houston citizenry optimistic about its personal futures, per the report.

A little about the study before delving in: The report was conducted by the esteemed Stephen Klineberg, founding director of Rice University's Kinder Institute for Urban Research and emeritus professor of sociology; and Robert Bozick, senior research fellow at the Kinder Institute.

This new survey was unveiled at the Kinder Institute's "Lunch-Out" recent virtual event. Interviews of some 1,051 Harris County adults were conducted between January 18 and March 29 by the National Opinion Research Center at the University of Chicago.

The full report is available online.

The No. 1 concern

Public health concerns, while rarely registering in previous surveys, were cited as the biggest problem facing Houstonians this year, according to a press release. Some 25 percent of respondents cited the pandemic or health-related issues.

Others — 20 percent — pointed to the economy as the biggest problem, that's up from 13 percent last year. Only 14 percent cited crime, and traffic dropped to 13 percent, down from 30 percent last year.

Highlighting a national socioeconomic disparity, 58 percent of Blacks and 66 percent of Hispanics said they had to risk exposure to the coronavirus to keep their jobs during the past year, per the report. That's compared to 41 percent of Asians and only 36 percent of whites.

Additionally, the report notes that Blacks and Hispanics were more likely (at 73 percent and 67 percent, respectively) to know someone who was hospitalized with or died as a result of having COVID-19, compared with whites (57 percent) and Asians (40 percent).

Mental health issues have arisen as a serious problem in equal numbers across ethnic communities. More than 50 percent of respondents — in all four groups — reported feeling more stress and experiencing more emotional problems during the past year, compared with 2020.

Jobs and the economy

Though Houston is an opportunity city, the Kinder Survey revealed that the percentage of Houston-area residents who had a positive view of the local job market dropped slightly, to 61 percent this year from 68 percent in 2020.

A mere 21 percent reported their economic situations were getting better, down from 34 percent in 2020. Notably — for the first time in the 40 years — of the survey, more respondents (25 percent) said their financial situations were getting worse than getting better.

Blacks and Hispanics were also more likely than Asians and whites to have experienced a loss of income and to have received help from government programs in the past year.

Race relations, immigration, and inequity

Positive ratings of relations among ethnic groups in the Houston area declined across the board, especially among Blacks. Whites and Hispanics were significantly more likely than in previous years to agree that Blacks are still a long way from having the same opportunities in life as whites.

The number of people who said the criminal justice system is biased against Blacks increased to 54 percent from 32 percent in 2015, when the question was last asked, per a release.

Weather, religion, and politics

Area residents were less likely than in previous surveys to say it's virtually certain the region will experience more severe storms in coming years (59 percent in 2021, compared with 81 percent in 2018 and 2020).

The number of religious Houstonians continues to decline, with more people than ever indicating they are not part of any faith tradition (22 percent today, compared with 8 percent in 2008) and do not consider religion to be an important part of their lives (26 percent, compared with 10 percent in 2008), per the study.

Meanwhile, 45 percent of those surveyed said they felt closer to the Democratic Party this year, while only 25 percent voiced support for the Republican Party.

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

7+ can't-miss Houston business and innovation events in June 2026

where to be

Editor's note: The FIFA World Cup comes to Houston this month, joined by major energy conferences and a lineup of fan-favorite, recurring events. Here’s what not to miss and how to register. Please note: this article may be updated to add more events.


June 1-4 — CLEANPOWER 2026 Conference and Exhibition

CLEANPOWER unites policymakers, experts, and corporate leaders to solve the challenges that none can solve alone. This must-attend, four-day conference is packed with cutting-edge discussions about wind, solar, storage, and transmission; dealmaking; networking; and fun.

This event begins June 1 at the George R. Brown Convention Center. Register here.

June 2 — Humans of Healthcare

Houston Methodist Center for Innovation will present its quarterly speaker series, Humans of Healthcare. The series will feature a panel of experts who will share about their career paths and discuss the nuances of the health care industry. This month's session will focus on today’s nursing landscape, the industry’s expectations of nurses and what career paths are possible in the field.

The event is Tuesday, June 2, from 5-6:30 p.m. at the Ion. Register here.

June 9 — Greentown Go Make Kickoff

Head to the Ion to celebrate the Greentown Go Make 2026 cohort. The open-innovation program with Shell Catalysts & Technologies and Technip Energies focuses on catalytic solutions for industrial decarbonization and the energy transition. Hear pitches from the founders and network with a select group of startups while enjoying food and drink.

This event is Tuesday, June 9, from 5:30-8 p.m. Register here.

June 9-10 — Texas Brain Economy Summit

The Center for Houston’s Future and UTMB are bringing the Texas Brain Economy Summit back to Houston this summer to continue to position the region as a global leader in brain health. Expect to hear from leaders of global institutions, including the World Economic Forum, U.S. Chamber of Commerce, McKinsey Health Institute, Global Brain Economy Initiative, Davos Alzheimer’s Collaborative, Business Collaborative for Brain Health (UsAgainstAlzheimer’s), Rice University, Memorial Hermann, MD Anderson and many others. Read InnovationMap's full preview of the event here.

This event begins Tuesday, June 9. Purchase tickets here.

June 10 — MIT Future of Healthcare Technology Forum

The MIT Club of South Texas will host an in-person forum to explore how innovation, government and policy are changing the healthcare industry. The event will feature MIT alumni and Houston healthcare leaders, including Dr. Tim Boone, dean of the Texas A&M School of Engineering Medicine; Cynthia Reinhart-King, chair of bioengineering at Rice University; Dr. Tony Lin, CEO and chairman emeritus of Kelsey-Seybold Clinic; and others.

This event is Wednesday, June 10, from 5:15-8:30 p.m. at the TAMU EnMed Building. Register here.

June 11 — Goals & Gigawatts: Houston Energy & Climate Week The Power of & Kickoff Party

Come watch the Mexico City FIFA opening match while celebrating energy and innovation at the Goals & Gigawatts Kickoff Party. The event will feature food, drinks, and a showcase on Houston Energy & Climate Week. Learn what to expect and how to get involved in HECW before closing the night with a DJ and karaoke.

This event is Thursday, June 11, from 1:30-6:30 p.m. Find more information here.

June 16-17 — Energy Projects Conference & Expo

The Energy Projects Conference & Expo (EPC Show) is the largest event in North America for professionals working at the heart of major energy projects. The essential event for engineering, construction, commissioning, operations and maintenance across multiple energy sectors brings together five leading conferences under one roof. Conference subjects span LNG exporting, hydrogen and ammonia, midstream, petrochem and refining, and sustainable aviation fuels.

This event begins June 16 at George R. Brown Convention Center. Register here.

June 25 – NASA Tech Talk

Every fourth Thursday of the month, NASA experts, including longtime engineer Montgomery Goforth, present on technology development challenges NASA’s Johnson Space Center and the larger aerospace community are facing, and how they can be leveraged by Houston’s innovation community. Stick around after for drinks and networking at Second Draught.

This event is Thursday, June 25, from 6-7 p.m. at the Ion. Register here.

Houston researchers report promising first in-human trial for implantable cancer therapy

cancer breakthrough

When it comes to cancer remedies, the treatment can be as challenging for the body as its cause. But what if immunotherapy could be localized? That’s precisely what a Houston team may soon make a reality.

Rice University researchers, in partnership with MD Anderson Cancer Center, recently published their findings from the first in-human trial of an implantable cancer-fighting treatment in the journal Clinical Cancer Research. The paper details testing of AVB-001, encapsulated cells engineered to release interleukin-2 (IL-2)—a naturally occurring signaling protein that boosts immunity—in the peritoneal cavities of 14 patients. The goal is to avoid the toxicity usually experienced with less targeted treatments, as well as find a solution to IL-2s’ abbreviated half-lives.

“Traditional IL-2 therapy has shown potent antitumor activity, but its clinical use has been limited by severe side effects and delivery challenges,” Omid Veiseh, director of the Rice Biotech Launch Pad, professor of bioengineering at Rice and a senior author on the study, said in a press release. “This platform allows us to localize and sustain cytokine exposure directly where tumors reside while minimizing systemic toxicity.”

Serous ovarian carcinoma is especially well-suited to the use of AVB-001 because it tends to spread throughout the abdomen. After a minimally invasive laparoscopic procedure, patients implanted with the cells were noted to tolerate the treatment well. Half of the enrolled patients’ cancer was stabilized, with several among them reporting extended signs of benefit. No maximum tolerated dose was reached and there were no life-threatening events tied to the study.

If that sounds like less-than-earth-shaking results, this is only the beginning. The capsules were implanted for about one week because IL-2 activity drops off after that. The researchers now know that further testing should include either higher levels, repeated doses, or a combination thereof, in order to create stronger advances.

The team has already made early headway on this next step. Preclinical studies in nonhuman primates were not only tolerated well, but without added toxicity, the apes had consistent pharmacological effects.

“This is a foundational step,” Veiseh explained. “We now have evidence that the platform is safe, biologically active and potentially scalable. The next phase is optimizing dosing and exploring combination therapies to unlock its full clinical potential.”

The combination would also include a checkpoint inhibitor, which might improve AVB-001’s tumor-fighting power. “What is exciting is that we are not just delivering a drug, we are programming a microenvironment,” added Dr. Amir Jazaeri, professor of gynecologic oncology at MD Anderson, member of the Rice Biotech Launch Pad’s clinical advisory board and a senior author on the study. “This opens the door to combination strategies that could amplify immune responses in ways that have not been feasible before.”